These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 5850269

  • 21. Accumulation and disappearance of 3H-5-hydroxytryptamine formed from 3H-tryptophan in mouse brain; effect of LSD-25.
    Schubert J, Nybäck H, Sedvall G.
    Eur J Pharmacol; 1970 May; 10(2):215-24. PubMed ID: 5446376
    [No Abstract] [Full Text] [Related]

  • 22. Some aspects of the effects of acute reserpine treatment on behaviour.
    GLOW PH.
    J Neurol Neurosurg Psychiatry; 1959 Feb; 22(1):11-32. PubMed ID: 13642073
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparative aspects of selected psychoactive compounds: biogenic amines, monoamine oxidase inhibitors, and lysergic acid diethylamide.
    Pscheidt GR.
    Comp Biochem Physiol; 1968 Jan; 24(1):249-65. PubMed ID: 4868883
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Lysergic acid diethylamide antagonism of certain drugs.
    BROWN BB.
    Ann N Y Acad Sci; 1957 Mar 14; 66(3):677-85. PubMed ID: 13425250
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA, Chinn C, Proudfit HK, Anderson EG.
    J Pharmacol Exp Ther; 1981 Apr 14; 217(1):99-104. PubMed ID: 6110778
    [Abstract] [Full Text] [Related]

  • 31. Comparison of the chronic and acute effects of D-lysergic acid diethylamide (LSD) treatment on rat brain serotonin and norepinephrine.
    Peters DA.
    Biochem Pharmacol; 1974 Jan 15; 23(2):231-7. PubMed ID: 4149793
    [No Abstract] [Full Text] [Related]

  • 32. Effects of lysergic acid diethylamide on the uptake and retention of brain 5-hydroxytryptamine in vivo and in vitro.
    Ziegler MG, Lovell RA, Freedman DX.
    Biochem Pharmacol; 1973 Sep 01; 22(17):2183-93. PubMed ID: 4270151
    [No Abstract] [Full Text] [Related]

  • 33. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV, Roberts S, Hill DF.
    Brain Res; 1975 Aug 22; 94(1):57-66. PubMed ID: 238721
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Photic evoked cortical potentials: interaction of reserpine, monoamine oxidase inhibition, and DOPA.
    Sabelli HC, Giardina WJ, Bartizal F.
    Biol Psychiatry; 1971 Aug 22; 3(3):273-80. PubMed ID: 5163812
    [No Abstract] [Full Text] [Related]

  • 37. Brain levels of tryptamine.
    Martin WR, Sloan JW, Christian ST, Clements TH.
    Psychopharmacologia; 1972 Aug 22; 24(3):331-46. PubMed ID: 5034937
    [No Abstract] [Full Text] [Related]

  • 38. The effect of D-lysergic acid diethylamide (LSD) upon shock elicited fighting in rats.
    Sheard MH, Astrachan DI, Davis M.
    Life Sci; 1977 Feb 01; 20(3):427-30. PubMed ID: 557157
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Interactions of monoamine oxidase inhibitors and reserpine: an EEG, gross behavioral and biochemical analysis.
    Bueno JR, Pscheidt GR, Himwich HE.
    Psychopharmacologia; 1968 Feb 01; 12(5):400-13. PubMed ID: 5723187
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.